Tumor microenvironment remodeling in oral cancer: Application of plant derived-natural products and nanomaterials

HS Budi, B Farhood - Environmental research, 2023 - Elsevier
Oral cancers consist of squamous cell carcinoma (SCC) and other malignancies in the
mouth with varying degrees of invasion and differentiation. For many years, different …

Veliparib (ABT-888), a PARP inhibitor potentiates the cytotoxic activity of 5-fluorouracil by inhibiting MMR pathway through deregulation of MSH6 in colorectal cancer …

S Paul, S Chatterjee, S Sinha, SR Dash… - Expert Opinion on …, 2023 - Taylor & Francis
Objective Sensitization of mismatch repair (MMR)-deficient colorectal cancer (CRC) cells by
5-Fluorouracil (5-FU) is well-documented. But not much is known about the treatment of …

Combination therapy as a promising way to fight oral cancer

JPN Silva, B Pinto, L Monteiro, PMA Silva, H Bousbaa - Pharmaceutics, 2023 - mdpi.com
Oral cancer is a highly aggressive tumor with invasive properties that can lead to metastasis
and high mortality rates. Conventional treatment strategies, such as surgery, chemotherapy …

Olaparib enhances the Resveratrol-mediated apoptosis in breast cancer cells by inhibiting the homologous recombination repair pathway

S Sinha, S Chatterjee, S Paul, B Das, SR Dash… - Experimental Cell …, 2022 - Elsevier
Although sensitization of BRCA-mutated, homologous recombination (HR)-deficient breast
cancer cells through PARP inhibitor is widely studied, not much is known about the …

[HTML][HTML] Nanostructures for site-specific delivery of oxaliplatin cancer therapy: Versatile nanoplatforms in synergistic cancer therapy

M Bagheri, MA Zandieh, M Daryab, SS Samaei… - Translational …, 2024 - Elsevier
As a clinically approved treatment strategy, chemotherapy-mediated tumor suppression has
been compromised, and in spite of introducing various kinds of anticancer drugs, cancer …

Combination of Resveratrol and PARP inhibitor Olaparib efficiently deregulates homologous recombination repair pathway in breast cancer cells through inhibition of …

S Sinha, S Paul, SS Acharya, C Das, SR Dash, S Bhal… - Medical Oncology, 2024 - Springer
Recently, we reported that a combination of a natural, bioactive compound Resveratrol
(RES) and a PARP inhibitor Olaparib (OLA) deregulated the homologous recombination …

Curcumin Alone and Combined With PI3K Inhibitors Elicits Positive Effects on Oropharyngeal Cancer Cell Lines Regardless of HPV Status

M Lukoceviciute, M Zupancic… - Anticancer …, 2024 - ar.iiarjournals.org
Background/Aim: Human papillomavirus positive (HPV+) oropharyngeal squamous cell
carcinoma (OPSCC) is rising in incidence. Compared to HPV-negative (HPV–) OPSCC …

Near infrared-responsive quinacrine–gold hybrid nanoparticles deregulate HSP-70/P300-mediated H3K14 acetylation in ER/PR+ breast cancer stem cells

SR Dash, C Das, B Das, AB Jena, S Paul, S Sinha… - …, 2024 - Taylor & Francis
Aim: This study aimed to determine if quinacrine–gold hybrid nanoparticles (QAuNPs)+ near-
infrared (NIR) deregulate HSP-70/P300 complex-mediated H3K14 acetylation in estrogen …

Quinacrine inhibits cMET-mediated metastasis and angiogenesis in breast cancer stem cells

B Das, C Sethy, S Chatterjee, SR Dash, S Sinha… - Journal of Cell …, 2023 - Springer
A trans-membrane receptor tyrosine kinase, cMET, belonging to the MET proto-oncogene
family, is responsible for cancer metastasis and angiogenesis. But not much is known about …

Scutellarin: pharmacological effects and therapeutic mechanisms in chronic diseases

S Nie, S Zhang, R Wu, Y Zhao, Y Wang… - Frontiers in …, 2024 - frontiersin.org
Scutellarin (SCU), a flavonoid glucuronide derived from Scutellaria barbata and Erigeron
breviscapus, exhibits broad pharmacological effects with promising therapeutic potential in …